Differentiating and growth inhibitory effects of diallyl disulfide on cancer cells

International Journal of Oncology

Volumn 11, Issue 1, 1997, Pages 181-185

  Lea, Michael A ^a   Ayyala, Uma S ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Diallyl disulfide; Differentiation; Erythroleukemia; Growth; Hepatoma

Indexed keywords

ACETYLCHOLINESTERASE; ALLYL SULFIDE; BUTYRIC ACID; DIALLYL DISULFIDE; DNA; HEMOGLOBIN; HEXAMETHYLENEBISACETAMIDE; LEUCINE; THYMIDINE; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROLEUKEMIA CELL; GROWTH INHIBITION; HEMOGLOBIN SYNTHESIS; HEPATOMA CELL; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030744052     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.1.181     Document Type: Article

References (5)

1. Dausch JG and Nixon DW: Garlic: a review of its relationship to malignant disease. Prev Med 19: 346-361, 1990.
2. Lau BHS, Tadi PP and Tosk JM: Allium sativum (garlic) and cancer prevention. Nutr Res 10: 937-948, 1990.
3. Dorant E, van den Brandt PA, Goldbohm RA, Hermus RJJ and Sturmans F: Garlic and its significance for the prevention of cancer in humans: a critical review. Br J Cancer 67: 424-429, 1993.
4. Sumiyoshi H and Wargovich MJ: Garlic (Allium sativum): a review of its relationship to cancer. Asia Pac J Pharmacol 4: 133-140, 1989.
5. Lea MA: Organosulfur compounds and cancer. In: Dietary Phytochemicals in Cancer Prevention and Treatment. American Institute for Cancer Research (ed). Plenum Press, New York, pp 147-154, 1996.